MarkWide Research - Global Market Intelligence Platform
Report Details
Historical Year
2020-2024
Base Year
2025
Forecast Period
2026-2036
Published Date
May 2026
No. of Pages
151 Pages
Delivery Format
PDF + Excel
Home›Industries›Healthcare›Testing Services›Rift Valley Fever Testing Market

Rift Valley Fever Testing Market Size, Share, and Industry Trends Forecast 2026-2036

The Rift Valley Fever Testing Market valued at $78.50 Million in 2026 is projected to expand to $151.77 Million by 2035, advancing at a 7.60% CAGR over the analysis window. Veterinary clinics across Sub-Saharan Africa are expanding their diagnostic procurement for zoonotic surveillance. WHO guidance on epidemic preparedness and the shift toward multiplex PCR platforms are reshaping procurement standards. Demand is concentrating in Kenya, where livestock export protocols and human outbreak response infrastructure require sustained testing capacity.

Rift Valley Fever Testing Market Analytics

Maintenance contracts for deployed diagnostic equipment is expanding as a recurring revenue layer that shifts vendor economics from one-time kit sales to sustained service relationships. Thermo Fisher Scientific leverages its installed base of real-time PCR systems to lock in multi-year service agreements across African reference laboratories. Bio-Rad Laboratories anchors its position through field calibration networks that reduce instrument downtime in remote veterinary stations. Abbott Laboratories differentiates by bundling rapid test reader hardware with predictive maintenance software that flags reagent expiry and thermal cycler drift before failure.

Rift Valley Fever testing encompasses molecular, immunological, and conventional methods for detecting RVFV antibodies or viral RNA in human, animal, and environmental specimens, with PCR assays typically targeting the L or M genome segments at 95% analytical specificity thresholds. The primary commercial purpose is to enable early outbreak detection, certify livestock for trade, and guide vector control programs in endemic zones. ELISA Kits occupy the mature volume tier where public-sector tenders prioritize cost-per-test metrics over sensitivity gains. Point-of-Care Testing represents the fastest-growing technology segment as battery-operated PCR miniaturization and lateral flow reader integration allow deployment beyond centralized labs. Molecular Diagnostics captures the premium margin pool where multiplex panels simultaneously screen RVFV alongside Crimean-Congo hemorrhagic fever and Lassa fever in high-containment settings.

WHO emergency use listing procedures and the African Union's Pan African Veterinary Vaccine Centre standards shape which assays gain procurement eligibility during outbreak response. Kenya's Veterinary Service Department and South Africa's Department of Agriculture, Land Reform and Rural Development enforce import testing protocols that directly determine kit demand cycles. Stakeholders must monitor how climate-driven vector range expansion into the Sahel and Horn of Africa alters the geographic prioritization of national reference laboratory buildouts versus decentralized field testing architectures.

Rift Valley Fever Testing Market Size and Forecast

Market Dynamics

Multiplex PCR platform standardization is compressing procurement cycles across veterinary and human health laboratories, forcing assay vendors to consolidate fragmented test menus into integrated outbreak-response panels that satisfy both WHO emergency use listing and national export certification requirements simultaneously.

Growth Catalysts

  • Climate-driven vector expansion:Aedes and Culex mosquito range shifts into the Sahel and Horn of Africa are triggering preemptive diagnostic infrastructure investments by Kenya's Veterinary Service Department and Ethiopia's National Animal Health Diagnostic and Investigation Center.
  • Livestock export protocols:Gulf Cooperation Council import requirements mandate RVFV-negative certification for ruminant shipments, creating sustained kit demand cycles tied to seasonal Hajj and Eid al-Adha trade windows.
  • WHO R&D Blueprint:The priority pathogen designation for Rift Valley fever accelerates emergency use listing pathways for novel assays, reducing time-to-market for validated molecular platforms during outbreak declarations.

Market Restraints

  • Cold chain dependency:PCR reagent stability requirements limit deployment to facilities with reliable -20°C storage, excluding remote pastoral surveillance posts in northern Kenya and southern Somalia.
  • Reference material scarcity:The African Union's Pan African Veterinary Vaccine Centre controls limited certified viral strain repositories, creating bottlenecks for assay validation and quality control across commercial manufacturers.
  • Substitution by syndromic surveillance:Human health ministries in resource-constrained settings prioritize undifferentiated febrile illness protocols over RVFV-specific testing during non-epidemic periods, displacing molecular demand.

Strategic Opportunities

  • Decentralized field architecture:Battery-operated PCR miniaturization enables deployment to district veterinary offices in Tanzania's Mwanza and Shinyanga regions, currently served only by centralized Dar es Salaam reference capacity.
  • One Health integration mandates:Kenya's revised National Strategy for the Prevention and Control of Zoonotic Diseases creates procurement frameworks that bundle human and animal testing budgets, favoring vendors with cross-sectoral assay portfolios.
  • Digital reader convergence:Lateral flow immunoassay readers with cloud-connected result logging satisfy World Organisation for Animal Health traceability requirements for transboundary livestock movement documentation.

Industry Challenges

  • Biosafety containment scarcity:BSL-3 laboratory capacity for live virus work concentrates in Nairobi, Dakar, and Pretoria, constraining field validation studies for novel assays targeting emergent lineages.
  • Multi-pathogen panel complexity:Simultaneous optimization of RVFV, Crimean-Congo hemorrhagic fever, and Lassa fever primer sets within single multiplex reactions demands specialized assay development expertise that pools in South African and Senegalese research institutes.

Report Scope

MarkWide Research
AttributesDetails
Report TitleRift Valley Fever Testing Market
Market Size in 2026$78.50 Million
Market Size in 2035$151.77 Million
CAGR (2026 – 2036)7.6%
Historical Year2020-2024
Base Year2025
Forecast Period2026-2036
Segmentation
Product Type: ELISA Kits, PCR Assays, Rapid Test Kits, Serological Tests
End User: Hospitals, Veterinary Clinics, Research Laboratories, Field Testing Units
Technology: Molecular Diagnostics, Immunodiagnostics, Conventional Diagnostics, Point-of-Care Testing
Application: Animal Health, Human Health, Environmental Monitoring, Epidemiological Studies
Companies CoveredAbbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens Healthcare GmbH, Merck KGaA, Promega, New England Biolabs, Illumina, Serum Institute of India, Others
Regions Covered
North America: US, Canada, Mexico
Europe: Germany, Italy, France, UK, Spain, Denmark, Sweden, Austria, Belgium, Finland, Turkey, Poland, Russia, Greece, Switzerland, Netherlands, Norway, Portugal, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Indonesia, Malaysia, Kazakhstan, Taiwan, Vietnam, Thailand, Philippines, Singapore, Australia, New Zealand, Rest of Asia Pacific
South America: Brazil, Argentina, Colombia, Chile, Peru, Rest of South America
Middle East & Africa: Saudi Arabia, UAE, Qatar, South Africa, Israel, Kuwait, Oman, North Africa, West Africa, Rest of MEA

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Rift Valley Fever Testing Market Evolving Landscape

Diagnostic platform convergence is collapsing the traditional separation between centralized reference laboratory workflows and point-of-need deployment, with hardware miniaturization and cloud connectivity enabling real-time epidemic intelligence generation from previously disconnected field sites.

Automated nucleic acid extraction integrated into cartridge-based PCR systems is automating sample-to-answer workflows previously requiring separate pipetting stations and trained molecular biologists. District veterinary laboratories in Kenya's Rift Valley Province are adopting these closed systems to process capillary blood from livestock without dedicated BSL-2 infrastructure. The technology is automating result turnaround from 48 hours to under 90 minutes, compressing the window between outbreak detection and vector control mobilization.

WHO emergency use listing procedures for in vitro diagnostics have tightened analytical specificity documentation requirements for multiplex panels, forcing manufacturers to submit lineage-specific validation data across African RVFV strains. The regulation is elevating development costs for assay developers without existing African field trial networks. East African Community member states are responding by harmonizing national regulatory review timelines to accelerate post-EUL procurement decisions.

Public-sector tender specifications are unbundling equipment procurement from reagent supply contracts, enabling reference laboratories to source consumables from secondary vendors compatible with their installed thermal cycler base. Kenya's Medical Research Institute and Uganda's Virus Research Institute have both issued split-source tenders in the past eighteen months. This pattern is most visible in East African markets where development partner financing for health security infrastructure has expanded instrument installation faster than original manufacturer reagent supply agreements can satisfy.

Rift Valley Fever Testing Market Segmentation

Rift Valley Fever Testing Market Segment

Diagnostic procurement for Rift Valley Fever testing fragments across four intersecting dimensions, each governing distinct margin structures and deployment constraints. Product type determines cold chain requirements and shelf stability, while technology choice dictates whether testing occurs in centralized BSL-3 facilities or decentralized field posts.

Product Type:

Supply concentration for reagent manufacturing clusters around PCR master mixes and monoclonal antibody production, with lyophilization capabilities limiting vendor participation in rapid test formats.

  • ELISA Kits:Enzyme-linked immunosorbent assays detect RVFV IgM and IgG antibodies in serum samples with established protocols requiring 2-4 hour incubation cycles. Kenya's Veterinary Service Department and Ethiopia's National Animal Health Diagnostic and Investigation Center procure these in bulk for livestock screening during export certification windows, constrained by batch-to-batch variability in antigen coating consistency.
  • PCR Assays:Real-time and conventional polymerase chain reaction platforms target the L or M genome segments at 95% analytical specificity thresholds, demanding -20°C reagent storage and trained molecular biologists. Reference laboratories in Nairobi, Dakar, and Pretoria anchor demand for these high-sensitivity formats, though cold chain gaps exclude deployment to northern Kenya's remote pastoral surveillance posts.
  • Rapid Test Kits:Lateral flow immunoassays deliver qualitative antibody detection in 15-20 minutes without instrumentation. District veterinary offices in Tanzania's Mwanza region adopt these where electricity and refrigeration remain unreliable.
  • Serological Tests:Complement fixation and virus neutralization assays serve confirmatory roles in reference settings. The African Union's Pan African Veterinary Vaccine Centre certifies strains for these classical methods.

PCR assays absorb the bulk of installed capacity in high-containment reference laboratories; rapid test kits are expanding most quickly into decentralized field architectures.

End User:

Procurement authority and budget cycles diverge sharply between human health ministries and agricultural departments, creating dual-track tender environments with incompatible technical specifications.

  • Hospitals:Acute care facilities in outbreak zones require diagnostic turnaround under 24 hours for patient isolation decisions. Kenya's Medical Research Institute and Uganda's Virus Research Institute anchor hospital-based molecular testing capacity.
  • Veterinary Clinics:Private and government veterinary stations process capillary blood from livestock for trade certification. Sub-Saharan Africa's expanding clinic networks are upgrading from rapid tests to automated nucleic acid extraction systems.
  • Research Laboratories:Academic and government research institutes conduct lineage surveillance and vaccine efficacy studies. BSL-3 containment scarcity concentrates this work in Nairobi, Dakar, and Pretoria.
  • Field Testing Units:Mobile and district-level deployment teams operate beyond centralized infrastructure. Battery-operated PCR miniaturization is enabling expansion into Tanzania's Shinyanga region and Kenya's Rift Valley Province.

Veterinary clinics command the largest procurement volumes through seasonal export certification cycles; field testing units are climbing the fastest as donor financing builds district-level capacity.

Technology:

Platform convergence is collapsing traditional separations between laboratory and point-of-need workflows, with cartridge-based automation compressing skill requirements and result turnaround.

  • Molecular Diagnostics:PCR and isothermal amplification methods deliver viral RNA detection with highest analytical sensitivity. Multiplex panels simultaneously screening RVFV alongside Crimean-Congo hemorrhagic fever and Lassa fever concentrate in high-containment settings with premium margin capture.
  • Immunodiagnostics:Antibody and antigen detection via ELISA and lateral flow formats dominates volume procurement where cost-per-test metrics override sensitivity optimization. Public-sector tenders in Kenya and Ethiopia prioritize these for livestock screening programs.
  • Conventional Diagnostics:Virus isolation and histopathology retain confirmatory roles in reference networks. The method's 5-7 day turnaround limits deployment to retrospective outbreak investigation.
  • Point-of-Care Testing:Battery-operated PCR miniaturization and lateral flow reader integration enable deployment beyond centralized laboratories. Cloud-connected result logging satisfies World Organisation for Animal Health traceability requirements for transboundary livestock movement.

Immunodiagnostics command the greatest procurement volume through mature public-sector tender channels; point-of-care testing is gaining share fastest as miniaturized PCR platforms penetrate district veterinary offices.

Application:

Regulatory frameworks and financing mechanisms differ fundamentally between animal health certification mandates and human outbreak response, with environmental monitoring emerging as a cross-cutting surveillance layer.

  • Animal Health:Livestock export protocols mandated by Gulf Cooperation Council import requirements create sustained kit demand tied to seasonal Hajj and Eid al-Adha trade windows. Kenya's Veterinary Service Department and South Africa's Department of Agriculture enforce testing mandates.
  • Human Health:Fever surveillance and outbreak response drive demand for rapid molecular confirmation. WHO emergency use listing procedures shape assay eligibility during epidemic declarations.
  • Environmental Monitoring:Vector and water source screening for RVFV RNA anticipates outbreak emergence before clinical cases appear. Climate-driven Aedes and Culex range expansion into the Sahel and Horn of Africa is triggering preemptive infrastructure investment.
  • Epidemiological Studies:Seroprevalence surveys and lineage mapping inform vaccine development and vector control strategy. Research institutes in Senegal and South Africa anchor this application segment.

Animal health absorbs the bulk of procurement volume through trade certification mandates; environmental monitoring is expanding most quickly as climate adaptation financing builds vector surveillance capacity.

Rift Valley Fever Testing Market Segmentation

Need this report tailored to your region?

Request specific countries, segments, or companies — tailored to your requirements.

Regional Outlook

Diagnostic kit production concentrates in North American and European manufacturing clusters, while consumption anchors in Sub-Saharan African veterinary and human health networks. This geographic split shapes cold chain logistics, regulatory harmonization efforts, and service contract economics across the value chain.

Kenya

Livestock export certification through the Veterinary Service Department and human outbreak response infrastructure drive sustained procurement cycles. The country's national zoonotic disease strategy bundles human and animal testing budgets under unified procurement frameworks. Nairobi anchors both BSL-3 reference capacity and regional distribution nodes serving the Horn of Africa.

South Africa

The Department of Agriculture, Land Reform and Rural Development enforces import testing protocols that synchronize with Gulf Cooperation Council trade windows. National health laboratory service networks concentrate multiplex PCR capacity in Pretoria and Cape Town. These clusters validate assays for emergent RVFV lineages before East African deployment.

Ethiopia

The National Animal Health Diagnostic and Investigation Center preemptively expands diagnostic infrastructure as climate-driven vector range shifts threaten the highlands. Pastoral surveillance posts in Afar and Somali regions remain underserved due to cold chain gaps. Addis Ababa-based reference laboratories coordinate with the African Union's Pan African Veterinary Vaccine Centre for strain certification.

Senegal

Dakar's Institut Pasteur de Dakar anchors West African BSL-3 containment capacity and serves as a validation hub for novel assay formats. The country's veterinary services coordinate transboundary surveillance across the Sahel. Research institutes here specialize in multi-pathogen panel optimization for Crimean-Congo hemorrhagic fever co-circulation zones.

United States

FDA-cleared assay platforms manufactured in California and Massachusetts supply African procurement channels through development partner financing mechanisms. The USDA Animal and Plant Health Inspection Service maintains reference materials for export certification alignment. Boston-area research clusters contribute primer design expertise for multiplex RVFV panels.

Rift Valley Fever Testing Market Competitive Landscape

Capital-heavy producers compete with asset-light designers across the diagnostic value chain, with integrated instrument-reagent vendors facing pressure from modular platform specialists. The market structure tilts toward consolidation at the premium molecular tier while fragmenting across rapid test commoditization. Three archetypes dominate: full-stack platform vendors, reagent specialists, and service-anchored maintenance providers. Competitive moves concentrate on multi-year service contract capture and field calibration network expansion rather than hardware differentiation alone.

Among North American-based platform vendors, Abbott Laboratories and Thermo Fisher Scientific occupy positions emphasizing installed base lock-in through predictive maintenance software and multi-year service agreements. Bio-Rad Laboratories represents the calibration-network archetype, anchoring field service density in remote veterinary stations. These three exemplify how vendor economics shift from transactional kit sales toward recurring revenue layers tied to instrument uptime guarantees and reagent supply continuity.

Leading Market Players
Abbott Laboratories
Bio-Rad Laboratories
Thermo Fisher Scientific
Siemens Healthcare GmbH
Merck KGaA
Promega
New England Biolabs
Illumina
Serum Institute of India
Others
Please note: The company list above is for reference and is subject to change. The final study will cover 15–20 leading companies in this market, and the final selection can be tailored to the client's specific requirements.

Value Network & Pricing Analysis

East African reference laboratory procurement concentration through Kenya's Medical Research Institute and Uganda's Virus Research Institute anchors contract-based long-term offtake pricing with multi-year service bundling. These buyers negotiate total cost-of-ownership metrics that compress reagent margins while elevating predictive maintenance software and field calibration premiums.

Pricing Analysis

Margin tightening in rapid test tiers reflects lyophilization capability scarcity among contract manufacturers. Three-tier pricing structure across multiplex PCR platforms, automated extraction systems, and lateral flow kits differentiates by analytical specificity certification and cold chain independence. Cost-down pressure on ELISA consumables accelerates because Kenyan Veterinary Service Department bulk tenders prioritize cost-per-test floors over sensitivity gains. District veterinary offices in Tanzania's Mwanza region exhibit highest price sensitivity; Nairobi's BSL-3 reference laboratories show lowest sensitivity due to donor financing buffers.

Supply Chain Analysis

Regional distribution centers in Nairobi, Dakar, and Pretoria operate hub-and-spoke patterns radiating to district veterinary posts across the Horn of Africa and Sahel. Manufacturing concentration clusters in California, Massachusetts, and Bavaria for PCR thermal cyclers and master mix reagents. Supply chains draw from monoclonal antibody production facilities in Switzerland and Singapore, lyophilization specialists in Germany, and battery miniaturization components from South Korean electronics suppliers. Single-source vulnerability concentrates in the African Union's Pan African Veterinary Vaccine Centre's certified viral strain repositories. Distribution runs through temperature-controlled logistics partnerships serving Gulf Cooperation Council export certification windows.

Rift Valley Fever Testing Market SWOT Analysis

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Analyst Recommendations

This market consolidates around vendors capturing multi-year service contracts as climate-driven outbreak frequency renders one-time kit economics unsustainable for smaller players.

For Market Incumbents: To counter modular platform specialists unbundling reagent supply from instrument lock-in, deepen field calibration network density in Tanzania's Shinyanga region and Ethiopia's Afar pastoral zones. Anchor position through predictive maintenance software integration that flags thermal cycler drift before failure, converting transactional buyers into captive service relationships. For New Entrants and Emerging Players: Development partner financing vehicles offer the most penetrable channel for battery-operated PCR miniaturization targeting district veterinary offices currently served only by centralized reference capacity. White-space exists in environmental monitoring applications for vector surveillance as climate adaptation funding builds preemptive infrastructure across the Sahel. Go-to-market through Kenya's revised National Strategy for the Prevention and Control of Zoonotic Diseases procurement frameworks that bundle human and animal testing budgets. For Investors and Strategic Acquirers: The window for entry favors assay developers with existing African field trial networks capable of satisfying WHO emergency use listing lineage-specific validation requirements. Long-term viability hinges on cross-pathogen panel optimization expertise pooling in South African and Senegalese research institutes. Watch for East African Community regulatory harmonization accelerating post-EUL procurement decisions as the inflection signal for platform consolidation timing.
Strategic InitiativeIndustry Significance
Multiplex Panel StandardizationConsolidates RVFV, CCHF, and Lassa fever testing into single outbreak-response workflows satisfying WHO emergency use listing.
Field Calibration Network ExpansionReduces instrument downtime in remote veterinary stations across Kenya's Rift Valley Province and Tanzania's Mwanza region.
Predictive Maintenance Software DeploymentFlags reagent expiry and thermal cycler drift before failure, locking in multi-year service agreements with African reference laboratories.
Battery-Operated PCR MiniaturizationEnables district-level deployment beyond centralized Dar es Salaam reference capacity into Tanzania's Shinyanga region.
One Health Procurement Framework AlignmentCaptures bundled human and animal testing budgets under Kenya's revised National Strategy for the Prevention and Control of Zoonotic Diseases.

Research Methodology

Document review covered WHO emergency use listing procedures, African Union Pan African Veterinary Vaccine Centre standards, and East African Community regulatory harmonization protocols, complemented by interviews with reference laboratory directors, veterinary service procurement officers, and molecular assay development leads. Secondary validation drew from Gulf Cooperation Council import certification requirements, Kenyan Veterinary Service Department tender specifications, and climate vector range expansion studies. Bottom-up instrument installation tracking across Nairobi, Dakar, and Pretoria reference networks was cross-referenced against top-down development partner financing disbursement patterns.

Historical deployment trajectories of PCR platforms and rapid test reader installations were cross-referenced against panel input from assay manufacturers and cold chain logistics providers. The analytical framework modeled product type, technology platform, end-user category, and application across the projection horizon, with CAGRs derived from instrument replacement cycles and seasonal export certification demand windows. Forecast inputs incorporated climate-driven vector range expansion timelines and WHO R&D Blueprint priority pathogen designation funding flows.

Caveats apply where biosafety containment scarcity constraining field validation studies, or African Union viral strain repository bottlenecks, could materially shift the outlook for novel assay time-to-market. Decision-makers should treat outputs as directional within the stated assumption set.

Need Custom Data?

Can't find what you're looking for? Our analysts can build a custom report tailored to your exact requirements.

1,000+

Global Clients

150+

Countries Covered

65,000+

Reports Available

Frequently Asked Questions

Why Work With MWR

Trusted by 1,000+ businesses across 150+ countries for high-stakes market decisions.

Ready to access intelligence that moves business?

Browse Reports →

Trusted by Global Leaders

From Fortune-level organizations to global SMEs, we provide intelligence for high-stakes decisions.

Multi-Language Support

Research available in French, German, Spanish, Chinese, and more.

ISO & IAF Certified

Globally aligned quality standards ensuring methodological discipline and data integrity.

Competitive Relevance

Free inclusion of 3–4 additional companies of your choice in every report.

Customized Insights

Tailored intelligence for market entry, niche expansion, or competitive benchmarking.

Post-Sale Assistance

Dedicated coordination to help interpret findings and address queries post-delivery.

Cutting-Edge Methods

Structured data collection, advanced analytics, and expert validation for reliable forecasts.

Value for Investment

Credible, structured intelligence at a cost that makes strategic sense.

What Our Clients Say

"

My team needed the real numbers on AI spending for our Reinvention Services work. MarkWide delivered. No fluff, just a clear look at where the money is actually going. It saved us about three weeks of guesswork.

Accenture

"

We recently leaned on MarkWide Research for a deep dive into the evolving snacking habits within Southeast Asia. Their report on the premium biscuit segment was exceptionally detailed, providing us with the specific consumer sentiment data we needed to refine our regional flavor strategy. It wasn't just a data dump; the cultural nuances they captured helped us avoid several localization pitfalls.

Mondelez

Director of Global Consumer Insights

"

For a recent engagement in the automotive sector, we needed rigorous, independent verification of EV battery recycling capacities. MWR delivered a report that made our work easier. Their ability to segment the competitive landscape by chemical composition and regional throughput was exactly the kind of 'hard-to-find' intel that our team was looking for.

BCG

"

We were looking for a report on Xcelerator ecosystem's potential and got in touch with MarkWide's team through one of my old colleagues who worked with them in the past. Their research team was incredibly polite and were always available for us which was important for my team as this was a custom project. Their methodology for tracking industrial IoT adoption gave our R&D heads the clarity needed to prioritize our next-gen sensor development.

Siemens

Head of Industrial Digitalization

"

During a recent M&A project, we needed a fast, reliable breakdown of the Fintech landscape in Southeast Asia. MarkWide came through with a report that was actually readable and focused on the metrics that matter. It saved my team a good week of primary research, which, given our timelines, was a massive win.

KPMG

Advisory Partner

"

We tapped MarkWide Research for a deep dive into the ESG reporting software market. At Deloitte, our clients expect us to have the most current insights, and this report didn't disappoint. It provided a breakdown of the competitive field that was far more detailed than what we were expecting.

Deloitte

Lead Consultant, Sustainability Services

"

For our semiconductor division at Samsung, the supply chain forecast from MarkWide was incredibly useful. It provided a realistic outlook on raw material availability that helped us refine our production timelines. No fluff, just the data we needed to make a tough call.

Samsung

"

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarkWide Research, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer. Their customer first approach and high value engagement model have given us great analysis and excellent value for money.

3M

"

I can share that it was a positive experience wherein MarkWide Research demonstrated flexibility to adapt to our needs and delivered an excellent report that fits all our requirements. Personally, I liked the timely follow up by the team and we will definitively reach out in case more research support is required.

VITO

Buy Now